Search results for "Liver cirrhosis."

showing 10 items of 598 documents

SURVEILLANCE PROGRAM FOR DIAGNOSIS OF HCC IN LIVER CIRRHOSIS: ROLE OF ULTRASOUND ECHOPATTERNS

2013

SURVEILLANCE PROGRAM HCC LIVER CIRRHOSIS ULTRASOUND ECHOPATTERNS
researchProduct

EFFETTI DELLA TERAPIA CON DIRECT ACTING ANTIVIRALS (DAAS) SUI PARAMETRI ECOGRAFICI DI IPERTENSIONE PORTALE

2017

Obiettivi dello studio: Tra gli end point della terapia antivirale con DAAs nella cirrosi HCV (LCHCV) oltre all' eradicazione del virus vi sono: la regressione della fibrosi e dell’ipertensione portale. Abbiamo valutato in pazienti LCHCV e risposta sostenuta (SVR) alla terapia con DAAs il comportamento dell’AST to Platelet Ratio Index (APRI) (marker indiretto di fibrosi) e di due segni ecografici di ipertensione portale: calibro della vena porta (cVP) e diametro longitudinale della milza (DLM). Materiali: 98 pazienti con LCHCV,al Baseline (BL) a fine terapia (FT) e tre mesi (PostT3) e 9 mesi dopo la fine della terapia (PostT9) eseguivano i test di funzionalità epatica e la conta piastrinica…

Settore MED/09 - Medicina InternaDIRECT ACTING ANTIVIRALS EPATITI CRONICHE CIRROSI IPERTENSIONE PORTALE ECOGRAFIADIRECT ACTING ANTIVIRALSChronic hepatitis Liver Cirrhosis Portal Hypertension Ultrasound
researchProduct

Two single nucleotide polymorphisms in the MICA gene and sMICA plasma levels are associated with hepatocellular carcinoma development in an Italian p…

2017

Background & Aims: We investigated the relationships between MICA polymorphisms, sMICA levels and hepatocellular carcinoma (HCC) risk in HCC patients with chronic hepatitis C virus (HCV) infection. Methods.154 HCV-related HCC cases, 93 HCV-related liver cirrhosis (LC) cases and 244 healthy controls were genotyped using KASPTM SNP method. Levels of plasma soluble MICA (sMICA) were measured in 132 HCC, 90 LC patients and in 78 controls. Results. Genotyping of MICA rs2596542 showed that G/G genotype was significantly more frequent in HCC than in controls and in HCC than in LC patients. As for MICA rs2596538 allele C and C/C genotype were significantly more frequent in HCC than in controls …

Settore MED/09 - Medicina InternaHCC liver cirrhosis HCV single nucleotide polymorphisms
researchProduct

Platelet changes in patients with hepatitis C virus-related liver cirrhosis after directly acting antiviral therapy

2017

Background and Purpose of the study:Thrombocytopenia is the most common haematological abnormality in patients with Liver Cirrhosis and it is caused by multiple factors. This study evaluated platelets (PLT) count changes in patients with HCV related LC after DAAs therapy. Materials and Methods: We enrolled 83 patients with LC. In all patients were evaluated liver function tests and PLT count at baseline (BL), at end of therapy (ET) and three months post treatment (PostT), Elastography and ultrasound (US) at BL, and US at PostT. LC diagnosis was histological in 13 patients, in 71 with liver stiffness >12 kPa. All patients were SVR (58 patients had DAAs therapy without, 25 with Ribavirin).…

Settore MED/09 - Medicina InternaPlatelets liver cirrhosis DAAs therapy
researchProduct

Glycemic homeostasis in chronic viral hepatitis and liver cirrhosis

2001

Settore MED/09 - Medicina Internachronic viral hepatitiliver cirrhosisGlycemic homeostasi
researchProduct

HCC therapies--lessons learned.

2014

The antiangiogenic multikinase inhibitor sorafenib was the first systemic agent to demonstrate a significant improvement in the overall survival of patients with advanced hepatocellular carcinoma (HCC), thereby introducing molecularly-targeted therapy in a therapeutic field of unmet needs. However, survival benefits for patients on sorafenib treatment are modest in clinical practice and advancing the field is far more challenging than initially anticipated. Molecular and clinical heterogeneity diminishes signals of potential activity in unselected populations, and underlying liver cirrhosis seals the fate of many novel targeted agents by causing relevant toxicity and mortality. The failure …

SorafenibLiver Cirrhosismedicine.medical_specialtyPhase iii trialsCarcinoma HepatocellularHepatologybusiness.industryLiver NeoplasmsGastroenterologymedicine.diseaseSystemic therapydigestive system diseasesSurgeryClinical Trials Phase III as TopicHepatocellular carcinomamedicineHumansIntensive care medicinebusinessmedicine.drugRandomized Controlled Trials as TopicNature reviews. Gastroenterologyhepatology
researchProduct

Segmented relationships to model erosion of regression effect in Cox regression

2010

In this article we propose a parsimonious parameterisation to model the so-called erosion of the covariate effect in the Cox model, namely a covariate effect approaching to zero as the follow-up time increases. The proposed parameterisation is based on the segmented relationship where proper constraints are set to accomodate for the erosion. Relevant hypothesis testing is discussed. The approach is illustrated on two historical datasets in the survival analysis literature, and some simulation studies are presented to show how the proposed framework leads to a test for a global effect with good power as compared with alternative procedures. Finally, possible generalisations are also present…

Statistics and ProbabilitybreakpointEpidemiologyProportional hazards modelLiver Cirrhosis BiliaryErosion (morphology)Lupus NephritisSet (abstract data type)Segmented regressionHealth Information ManagementNonlinear DynamicsRegression toward the meanCox modelCovariateStatisticsEconometricsHumansComputer SimulationSettore SECS-S/05 - Statistica SocialeSettore SECS-S/01 - Statisticaerosion of effectStatistical hypothesis testingMathematicsFollow-Up StudiesProportional Hazards Models
researchProduct

Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.

2018

Nonalcoholic fatty liver disease (NAFLD) affects 25% of the global adult population with a range of 13.5% in Africa and 31.8% in the Middle East. Nonalcoholic fatty liver disease is closely associated with a constellation of metabolic comorbidities which include: obesity, type 2 diabetes mellitus, hypertension, and hypercholesteremia. In fact, the increasing number of metabolic comorbidities not only increases the prevalence of NAFLD but also places patients at higher risk for progressive liver disease. As such, NAFLD is presently among the top etiologies for hepatocellular carcinoma and an indication for liver transplantation (LT) in the United States. Therefore, the following recommendati…

United StateLiver Cirrhosismedicine.medical_specialtyCarcinoma HepatocellularTissue and Organ ProcurementWaiting ListsLiver Cirrhosimedicine.medical_treatmentComorbidity030230 surgeryLiver transplantationdigestive system03 medical and health sciencesLiver disease0302 clinical medicineNon-alcoholic Fatty Liver DiseaseRisk FactorsInternal medicineEpidemiologyNonalcoholic fatty liver diseasePrevalenceMedicineHumansMetabolic SyndromeTransplantationbusiness.industryRisk FactorIncidencePatient SelectionLiver Neoplasmsnutritional and metabolic diseasesType 2 Diabetes Mellitusmedicine.diseaseComorbidityObesitydigestive system diseasesUnited StatesLiver TransplantationLiver NeoplasmWaiting ListDisease Progression030211 gastroenterology & hepatologyMetabolic syndromebusinessHumanTransplantation
researchProduct

Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients.

2013

Background and aims: Lower 25-Hydroxyvitamin D (25[OH]D) serum lev- els have been associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients (G1CHC). In addition, a recent genome-wide study identified genetic variants (rs12785878, near dehydrocholesterol reduc- tase, DHCR7; rs10741657, near CYP2R1; and rs7041, near vitamin D binding protein, GC) affecting 25(OH)D serum levels in healthy populations. We aimed to assess the association between vitamin D serum levels and its genetic determinants, with the severity of liver fibrosis. Material and methods: Two hundred sixty patients with biopsy-proven G1CHC were consecutively evaluated. The 25(OH)D serum levels wer…

VitaminAdultLiver CirrhosisMaleSerummedicine.medical_specialtyOxidoreductases Acting on CH-CH Group DonorsGenotypeHepatitis C virusSingle-nucleotide polymorphismHepacivirusBiologyReductasemedicine.disease_causeGastroenterologychemistry.chemical_compoundFibrosisVirologyInternal medicineGenotypemedicineVitamin D and neurologyHumansVitamin DCytochrome P450 Family 2Chromatography High Pressure LiquidHCV VITAMIN D DHCR7Settore MED/12 - GastroenterologiaPolymorphism GeneticHepatologyVitamin D-Binding ProteinHepatitis C ChronicMiddle Agedmedicine.diseaseInfectious DiseaseschemistryImmunologyCholestanetriol 26-MonooxygenaseFemaleSteatosisJournal of viral hepatitis
researchProduct

Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach

2021

Background & aims Liver fibrosis holds a relevant prognostic meaning in primary biliary cholangitis (PBC). Non-invasive fibrosis evaluation using vibration-controlled transient elastography (VCTE) is routinely performed. However, there is limited evidence on its accuracy at diagnosis in PBC. We aimed to estimate the diagnostic accuracy of VCTE in assessing advanced fibrosis at disease presentation in PBC. Approach & results We collected data from 167 consecutive treatment-naive PBC patients who underwent liver biopsy(LB) at diagnosis at six Italian centers. VCTE examinations were completed within 12 weeks of LB. Biopsies were scored by two blinded expert pathologists, according to Ludwig sy…

area under curve0301 basic medicinemedicine.medical_specialtyliver cirrhosisDiagnostic accuracyrisk stratificationPBCGastroenterologyprimary biliary cholangitiarea under curve; elasticity imaging techniques; female; humans; liver cirrhosis; biliary; male; middle aged; ROC curve; sensitivity and specificityTherapy naive03 medical and health sciences0302 clinical medicinemaleFibrosisInternal medicinemiddle agedmedicinehumansHepatologyReceiver operating characteristicmedicine.diagnostic_testLiver Cirrhosis Biliarybusiness.industryOriginal Articlesmedicine.diseasetransient elastographyROC curveelasticity imaging techniquesAutoimmune Cholestatic and Biliary Diseasefemale030104 developmental biologysensitivity and specificityLiver biopsyCohortOriginal Article030211 gastroenterology & hepatologydiagnostic accuracyCut-offTransient elastographybusinessfibrosibiliary
researchProduct